Richard S. Casten serves as Executive at Baudax Bio, Inc., where they oversee executive responsibilities. Since joining the company, Richard S. Casten has executed 5 insider transactions totaling $80.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 20, 2021 involved purchasing 50,000 shares valued at $25.5K.
Richard S. Casten currently holds 200,000 shares of Baudax Bio, Inc. (BXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard S. Casten has been a net buyer of BXRX stock. They have purchased $80.5K and sold $0 worth of shares.
Richard S. Casten's most recent insider trade was on Aug 20, 2021, when they purchased 50,000 shares at $0.51 per share.
Get notified when new Form 4 filings are submitted
| $0.79 |
| Discretionary |
| Mar 15, 2021 | BXRX | $35.3K | Purchase | 25,000 | $1.41 | Discretionary |
| Mar 8, 2021 | BXRX | $0 | Award | 85,000 | $N/A | Discretionary |
| Mar 8, 2021 | BXRX | $0 | Award | 15,000 | $N/A | Discretionary |